FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Biodexa Pharmaceuticals FCF Yield % Related Terms
Biodexa Pharmaceuticals FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:5MP2 vs CASIF, OGEN, ELOX: FCF Yield % Comparison
For the Biotechnology subindustry, Biodexa Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biodexa Pharmaceuticals FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Biodexa Pharmaceuticals's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Biodexa Pharmaceuticals's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biodexa Pharmaceuticals (STU:5MP2) has a FCF Yield % of -0.01 as of Jun. 25, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Biodexa Pharmaceuticals and its competitors. According to the industry distribution chart, Biodexa Pharmaceuticals ranks #1387 out of 1418 companies in the Biotechnology industry, placing it in the top 97.8%.
Is Biodexa Pharmaceuticals' FCF Yield % too high?
Biodexa Pharmaceuticals' current FCF Yield % is -0.01. Based on the distribution chart, Biodexa Pharmaceuticals ranks #1387 out of 1418 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Biodexa Pharmaceuticals has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Biodexa Pharmaceuticals' FCF Yield % compare to CASIF and OGEN?
According to the Biotechnology industry distribution chart, Biodexa Pharmaceuticals ranks #1387 out of 1418 companies for FCF Yield %. This places Biodexa Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Biodexa Pharmaceuticals and its competitors. Biodexa Pharmaceuticals's current FCF Yield % is -0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biodexa Pharmaceuticals stock overvalued right now?
Biodexa Pharmaceuticals (STU:5MP2) has a current FCF Yield % of -0.01. The stock's GF Value™ is €95,593.41, compared to a current price of €110,400.00 — trading 15.5% above its estimated fair value. The current FCF Yield % is -0.01. Biodexa Pharmaceuticals' overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Biodexa Pharmaceuticals (STU:5MP2), the current FCF Yield % is -0.01 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Biodexa Pharmaceuticals (STU:5MP2) Overvalued in 2026?
Based on GuruFocus' analysis, Biodexa Pharmaceuticals stock appears to be overvalued.
The current stock price of €110,400.00 is trading 15.5% above its estimated GF Value™ of €95,593.41.
Key valuation signals for STU:5MP2:
FCF Yield %: -0.01
GF Value™: €95,593.41 vs. price of €110,400.00 (15.5% above fair value)
No single metric tells the full story. See the STU:5MP2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
10GF Score
Get the complete analysis for STU:5MP2
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:5MP2 has been successfully added to your 
